Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH)
CUSIP: 05156V102
Q1 2015 13F Holders as of 31 Mar 2015
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 132,929,348
- Total 13F shares
- 7,607,904
- Share change
- -876,506
- Total reported value
- $33,247,000
- Price per share
- $4.37
- Number of holders
- 11
- Value change
- -$3,826,120
- Number of buys
- 4
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 05156V102?
CUSIP 05156V102 identifies AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 05156V102:
Top shareholders of AUPH - Aurinia Pharmaceuticals Inc. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
1.9%
|
2,546,843
|
$9,271,000 | — | 31 Dec 2014 | |
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
1.9%
|
2,474,076
|
$9,006,000 | — | 31 Dec 2014 | |
| GREAT POINT PARTNERS LLC |
13F
|
Company |
1.9%
|
2,485,576
|
$8,883,000 | — | 31 Dec 2014 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.55%
|
727,669
|
$2,599,000 | — | 31 Dec 2014 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.1%
|
133,333
|
$485,000 | — | 31 Dec 2014 | |
| Cheyne Capital Management (UK) LLP |
13F
|
Company |
0.07%
|
90,000
|
$323,000 | — | 31 Dec 2014 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
12,500
|
$46,000 | — | 31 Dec 2014 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
11,365
|
$41,000 | — | 31 Dec 2014 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
3,048
|
$11,000 | — | 31 Dec 2014 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
171
|
$1,000 | — | 31 Dec 2014 |
Institutional Holders of Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) as of Q1 2015
As of 31 Mar 2015,
Aurinia Pharmaceuticals Inc. - Common Shares, no par value (AUPH) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,607,904 shares.
The largest 10 holders included
NEA Management Company, LLC, GREAT POINT PARTNERS LLC, RA CAPITAL MANAGEMENT, LLC, BAKER BROS. ADVISORS LP, Longwood Capital Partners LLC, MILLENNIUM MANAGEMENT LLC, DEUTSCHE BANK AG\, Lombard Odier Asset Management (USA) Corp, Cheyne Capital Management (UK) LLP, and ROYAL BANK OF CANADA.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2015 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2015 vs Q4 2014 Across Filers
Q4 2014 holders
9
Q1 2015 holders
11
Holder diff
2
| Investor | Q4 2014 Shares | Q1 2015 Shares | Share Diff | Share Chg % | Q4 2014 Value $ | Q1 2015 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.